Showing results (891-900 of 1,050) with videos related to
Sort By:
Pageof 105
European Journal of Heart Failure|March 2, 2026
Rationale and design of a randomized, sham-controlled, clinical trial for evaluation of the Edwards APTURE transcatheter shunt system (ALT-FLOW II)Dean J Kereiakes, Ryan J Tedford, JoAnn Lindenfeld, et al.The Journal of Biological Chemistry|July 11, 2020
Cathepsin A contributes to left ventricular remodeling by degrading extracellular superoxide dismutase in miceMathias Hohl, Manuel Mayr, Lisa Lang, et al.The Journal of Infectious Diseases|January 17, 2024
Torque Teno Virus Load Is Associated With Centers for Disease Control and Prevention Stage and CD4+ Cell Count in People Living With Human Immunodeficiency Virus but Seems Unrelated to AIDS-Defining Events and Human Pegivirus LoadPia L Esser, Gibran H Rubio Quintanares, Bettina Langhans, et al.Heart Failure Reviews|May 15, 2012
Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressureMihai Gheorghiade, Muthiah Vaduganathan, Andrew Ambrosy, et al.Journal of the American College of Cardiology|February 28, 2024
Implications of Atrial Fibrillation for Guideline-Directed Therapy in Patients With Heart Failure: JACC State-of-the-Art ReviewJoshua D Newman, Eileen O'Meara, Michael Böhm, et al.European Journal of Heart Failure|June 15, 2022
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of CardiologyPeter Seferović, Dimitrios Farmakis, Antoni Bayes-Genis, et al.European Heart Journal|September 23, 2017
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized studyDenise Hilfiker-Kleiner, Arash Haghikia, Dominik Berliner, et al.European Journal of Heart Failure|March 21, 2019
Rationale and design of the DIGIT-HF trial (DIGitoxin to Improve ouTcomes in patients with advanced chronic Heart Failure): a randomized, double-blind, placebo-controlled studyUdo Bavendiek, Dominik Berliner, Lukas Aguirre Dávila, et al.European Journal of Heart Failure|March 28, 2023
Health status across major subgroups of patients with heart failure and preserved ejection fractionTariq Jamal Siddiqi, Stefan D Anker, Gerasimos Filippatos, et al.Journal of the American College of Cardiology|September 25, 2024
Asymptomatic vs Symptomatic Hypotension With Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction in PARADIGM-HFShingo Matsumoto, Li Shen, Alasdair D Henderson, et al.Pageof 105